Introduction Pulmonary embolism is a common cause of cardiopulmonary mortality and
morbidity worldwide. Survivors of acute pulmonary embolism may experience dyspnea …

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a life‐threatening
complication of a pulmonary embolism (PE) whose incidence and predictors are not …

Background Residual pulmonary vascular obstruction (RPVO) is common following
pulmonary embolism (PE) but its association with fibrin clot properties is poorly understood …

Background We aimed to validate and to refine current recurrent venous thromboembolism
(VTE) risk classification. Methods We performed a post hoc analysis of a multicentre cohort …

Background Residual perfusion defects (RPD) after pulmonary embolism (PE) are common.
Primary aim This study aimed to determine the prevalence of RPD in a cohort diagnosed …

Objective Major progress in reperfusion strategies has substantially improved the short-term
outcomes of patients with pulmonary embolism (PE), however, up to 50% of patients report …

Introduction Quantifying the pulmonary vascular obstruction index (PVOI) is essential for the
management of patients with pulmonary embolism or chronic thromboembolic pulmonary …

Background Residual pulmonary vascular occlusion (RPVO) affects one half of patients after
a pulmonary embolism (PE). The relationship between the risk factors and therapeutic …

Background The incidence of pulmonary embolism (PE) has been on the rise annually.
Despite receiving regular sequential anticoagulation therapy, some patients with non-high …

Acute pulmonary embolism (aPE) is one of the leading causes of morbidity and mortality and
its global incidence is approximately 1/1000 persons per year [1]. The estimated mortality of …